购物车
- 全部删除
- 您的购物车当前为空
YK-3-237 (B-[2-Methoxy-5-[(1E)-3-oxo-3-(3,4,5-trimethoxyphenyl)-1-propen-1-yl]phenyl]boronic acid) 是 SIRT1 激活剂,靶向突变体 p53。它抑制三阴性乳腺癌细胞的增殖。
为众多的药物研发团队赋能,
让新药发现更简单!
YK-3-237 (B-[2-Methoxy-5-[(1E)-3-oxo-3-(3,4,5-trimethoxyphenyl)-1-propen-1-yl]phenyl]boronic acid) 是 SIRT1 激活剂,靶向突变体 p53。它抑制三阴性乳腺癌细胞的增殖。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 219 | 现货 | |
2 mg | ¥ 375 | 现货 | |
5 mg | ¥ 847 | 现货 | |
10 mg | ¥ 1,460 | 现货 | |
25 mg | ¥ 2,950 | 现货 | |
50 mg | ¥ 4,360 | 现货 | |
100 mg | ¥ 6,190 | 现货 | |
200 mg | ¥ 8,530 | 现货 | |
500 mg | ¥ 12,600 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 869 | 现货 |
产品描述 | YK-3-237 (B-[2-Methoxy-5-[(1E)-3-oxo-3-(3,4,5-trimethoxyphenyl)-1-propen-1-yl]phenyl]boronic acid) reduces acetylation of mtp53 and exhibits anti-proliferative effects toward triple-negative breast cancer (TNBC) cells carrying mtp53. |
体外活性 | YK-3-237 activates SIRT1 enzyme activities in vitro and deacetylation of both mtp53 in a SIRT1-dependent manner. |
别名 | B-[2-Methoxy-5-[(1E)-3-oxo-3-(3,4,5-trimethoxyphenyl)-1-propen-1-yl]phenyl]boronic acid |
分子量 | 372.18 |
分子式 | C19H21BO7 |
CAS No. | 1215281-19-8 |
Smiles | COc1ccc(\C=C\C(=O)c2cc(OC)c(OC)c(OC)c2)cc1B(O)O |
密度 | 1.26 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMF: 30 mg/mL (80.60 mM) Ethanol: 10 mg/mL (26.86 mM) DMSO: 30 mg/mL (80.60 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容